boric acid has been researched along with fluconazole in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Shinohara, YT; Tasker, SA | 1 |
| Ringdahl, EN | 1 |
| Banerjee, U; Dadhwal, V; Goswami, D; Goswami, R; Kochupillai, N; Mandal, P; Ray, D; Sreenivas, V | 1 |
| Banerjee, U; Dadhwal, V; Goswami, D; Goswami, R; Kochupillai, N; Ray, D | 1 |
| Balbinot, A; Bianco, A; Catavitello, C; D'Antonio, D; D'Antonio, F; Savini, V | 1 |
| Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S | 1 |
| Gracely, E; Nyirjesy, P; Powell, AM | 1 |
| Aklamli, M; Amiri, MM; Arianpour, N; Khameneie, KM; Roozegar, R | 1 |
| Sobel, JD; Sobel, R | 1 |
| Gerstein, AC; Salama, OE | 1 |
| Becker, M; File, B; Nyirjesy, P; Sobel, R | 1 |
2 review(s) available for boric acid and fluconazole
| Article | Year |
|---|---|
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles | 2000 |
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests | 2018 |
3 trial(s) available for boric acid and fluconazole
| Article | Year |
|---|---|
Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Boric Acids; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Middle Aged; Suppositories; Vagina | 2007 |
Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Diabetes Mellitus, Type 2; Female; Fluconazole; Humans; Middle Aged; Prospective Studies; Suppositories; Time Factors; Treatment Outcome | 2007 |
FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS--NEW WORDS ABOUT OLD ISSUE.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Fluconazole; Humans; Iran; Secondary Prevention; Treatment Outcome | 2013 |
6 other study(ies) available for boric acid and fluconazole
| Article | Year |
|---|---|
Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intravaginal; Adult; Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Fluconazole; Humans; Suppositories | 1997 |
Azole resistant Candida glabrata vulvovaginitis treated with boric acid.
Topics: Adult; Antifungal Agents; Boric Acids; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Insecticides; Itraconazole; Treatment Outcome; Vulvovaginitis | 2009 |
Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Boric Acids; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cell Adhesion; Epithelial Cells; Female; Fluconazole; Fungal Proteins; Hemolysis; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Phospholipases; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Saccharomyces cerevisiae; Vagina; Virulence Factors; Young Adult | 2012 |
Non-albicans Candida Vulvovaginitis: Treatment Experience at a Tertiary Care Vaginitis Center.
Topics: Adult; Aged; Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Middle Aged; Tertiary Healthcare; Treatment Outcome | 2016 |
Differential Response of
Topics: Antifungal Agents; Boric Acids; Candida; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests | 2022 |
Fluconazole-Resistant Candida albicans Vaginal Infections at a Referral Center and Treated With Boric Acid.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Referral and Consultation; Retrospective Studies | 2023 |